X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Piramal Healthcare Fact Sheet, Piramal Healthcare Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Piramal Healthcare Fact Sheet   (NCHP)

Here is the latest financial fact sheet of Piramal Healthcare. For more details, see the Piramal Healthcare quarterly results and Piramal Healthcare share price and chart. For a sector overview, read our pharmaceuticals sector report.

PIRAMAL ENTERPRISES Price History

Price Rs 2,556.5
Mkt Cap Rs m 441,150
Vol '000 10.5
P/E X 8.9
P/CF X 30.1
EPS (TTM) Rs 285.8
% ch % 1.2
No. of shares m 172.56
% ch week % 3.5
% ch 1-mth % 0.4
% ch 12-mth % -12.1
52 week H/L Rs 3,009.6/2,279.1
(As on Jul 18, 2018 03:37:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PIRAMAL ENTERPRISES Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
PIRAMAL ENTERPRISES EQUITY SHARE DATA
High Rs6256489491,0652,095 
Low Rs3954835228051,025 
Sales per share (Unadj.) Rs204.0260.9296.9367.5492.8 
Earnings per share (Unadj.) Rs-13.2-29.1165.252.472.6 
Diluted earnings per shareRs-13.2-29.1165.252.472.6 
Cash flow per share (Unadj.) Rs-1.0-14.7182.067.294.7 
Dividends per share (Unadj.) Rs17.5052.5020.0017.5021.00 
Adj. dividends per shareRs17.5052.5020.0017.5021.00 
Dividend yield (eoy) %3.49.32.71.91.3 
Book value per share (Unadj.) Rs621.4540.2778.0750.4862.5 
Adj. book value per shareRs621.4540.2778.0750.4862.5 
Shares outstanding (eoy) m172.56172.56172.56172.56172.56 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x2.52.22.52.53.2 
Avg P/E ratio x-38.7-19.54.517.821.5 
P/CF ratio (eoy) x-496.3-38.34.013.916.5 
Price / Book Value ratio x0.81.00.91.21.8 
Dividend payout %-132.9-180.712.133.428.9 
Avg Mkt Cap Rs m87,99797,583126,901161,344269,194 
No. of employees `0003.03.02.43.84.0 
Total wages/salary Rs m7,96511,37012,94816,83117,939 
Avg. sales/employee Rs Th11,828.614,969.221,167.816,763.221,190.3 
Avg. wages/employee Rs Th2,676.53,779.85,350.24,449.04,470.1 
Avg. net profit/employee Rs Th-763.7-1,666.911,776.72,391.63,120.0 
PIRAMAL ENTERPRISES INCOME DATA
Net Sales Rs m35,20245,02751,22663,41585,037 
Other income Rs m1,7932,2132,5422,5172,338 
Total revenues Rs m36,99447,24053,76865,93287,374 
Gross profit Rs m4,3176,3918,85516,77234,991 
Depreciation Rs m2,0962,4692,8992,5553,817 
Interest Rs m5,75010,4965,1069,59120,310 
Profit before tax Rs m-1,736-4,3613,3927,14413,202 
Minority Interest Rs m-56-831,9421,699 
Prior Period Items Rs m-42-311,59300 
Extraordinary Inc (Exp) Rs m-1911426,962457-100 
Tax Rs m2486283,4504952,281 
Profit after tax Rs m-2,273-5,01428,5009,04712,520 
Gross profit margin %12.314.217.326.441.1 
Effective tax rate %-14.3-14.4101.76.917.3 
Net profit margin %-6.5-11.155.614.314.7 
PIRAMAL ENTERPRISES BALANCE SHEET DATA
Current assets Rs m40,87642,32447,70144,92887,590 
Current liabilities Rs m81,51593,50847,999103,802185,578 
Net working cap to sales %-115.4-113.7-0.6-92.8-115.2 
Current ratio x0.50.51.00.40.5 
Inventory Days Days5653474231 
Debtors Days Days6258585648 
Net fixed assets Rs m20,76822,58567,73578,803108,523 
Share capital Rs m345345345345345 
"Free" reserves Rs m105,09189,562133,910129,138148,481 
Net worth Rs m107,23693,211134,255129,484148,826 
Long term debt Rs m11,61026,79636,87374,740144,957 
Total assets Rs m202,521215,045220,026309,797482,394 
Interest coverage x0.70.61.71.71.7 
Debt to equity ratio x0.10.30.30.61.0 
Sales to assets ratio x0.20.20.20.20.2 
Return on assets %1.72.515.36.06.8 
Return on equity %-2.1-5.421.27.08.4 
Return on capital %3.15.121.79.412.0 
Exports to sales %22.721.519.517.90 
Imports to sales %10.49.38.56.90 
Exports (fob) Rs m7,9879,68710,00911,3620 
Imports (cif) Rs m3,6664,2094,3744,3640 
Fx inflow Rs m8,89110,51712,01014,43515,001 
Fx outflow Rs m4,3395,0065,7405,1835,150 
Net fx Rs m4,5525,5106,2709,2539,851 
PIRAMAL ENTERPRISES CASH FLOW
From Operations Rs m -15,705 -16,044 -22,069 -69,562 -100,393 
From Investments Rs m -16,645 14,829 61,771 -6,040 -24,202 
From Financial Activity Rs m 32,807 1,258 -38,646 75,439 135,705 
Net Cashflow Rs m 458 43 1,056 -163 11,110 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 52.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 4.0%
FIIs 26.6%
ADR/GDR 0.0%
Free float 16.5%
Shareholders 93,274
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Piramal Tower, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013
E-MAIL complianceofficer.phl@piramal.com WEB www.piramal.com
TELEPHONE (022) 3046 7839 FAX (022) 3046 7855
SECTOR PHARMACEUTICALS GROUP AJAY PIRAMAL
TR AGENT Link Intime India, C13, Pannalal Silk Mills Compd., LBS Marg, Mumbai-78
AUDITOR Price Waterhouse
CHM: Ajay G. Piramal COMP SEC: Leonard D' Souza YEAR OF INC: 1947 BSE CODE: 500302 FV (Rs): 2 DIV YIELD (%): 0.8

More Pharmaceuticals Company Fact Sheets:   WOCKHARDT LTD.  TORRENT PHARMA  NOVARTIS  ALEMBIC PHARMA  SUVEN LIFE  

Compare PIRAMAL ENTERPRISES With:   WOCKHARDT LTD.  TORRENT PHARMA  NOVARTIS  ALEMBIC PHARMA  SUVEN LIFE  

Compare PIRAMAL ENTERPRISES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Lower; Tata Steel & Vedanta Top Losers(Closing)

Indian share markets erased early gains to end lower today, as the opposition parties tabled a no-confidence motion against Prime Minister Narendra Modi's government.

Views on news

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY18); Net Profit Up 1230.7% (Quarterly Result Update)

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 39 bn (up 1230.7% YoY). Sales on the other hand came in at Rs 30 bn (up 21.5% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES - ACTAVIS COMPARISON

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS